Dr. Pavan Reddy has been recognized as an author in a JAMA Oncology, part of the American Medical Association, published trial that focused on clinical outcomes for women diagnosed with breast cancer and with a high recurrence score (RS) who received adjuvant chemotherapy plus endocrine therapy in a recent TAILORx trial. This trial brought forth positive outcomes of freedom from recurrence of breast cancer at a distant site and freedom from recurrence, second primary cancer, and death. This was conducted among 9,719 eligible women, with an average age of 56 years and recurrence scores of 26-100. CCK is proud of our physician’s and their constant part in the ever-growing community of oncology research. To read more about this study or to view the article in it’s entirety, see below.
Published by JAMA Oncology - A Secondary Analysis of the TAILORx Randomized Clinical Trial
